Skip to content

Ocular Surface Observation in Patients with Systemic Immune Diseases

Ocular Surface Observation in Patients with Systemic Immune Diseases

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400086597
Enrollment
Unknown
Registered
2024-07-07
Start date
2021-04-21
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic Immune Diseases

Interventions

Patients with Sjogren's Syndrome:Collect the complete medical history, specialized ocular surface condition, and tear samples for protein and PCR analysis from each patient. Obtain conjunctival impres
Patients with Systemic Lupus Erythematosus:Collect the complete medical history, specialized ocular surface condition, and tear samples for protein and PCR analysis from each patient. Obtain conjuncti
Patients with Rheumatoid Arthritis:Collect the complete medical history, specialized ocular surface condition, and tear samples for protein and PCR analysis from each patient. Obtain conjunctival impr
Patients with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis:Collect the complete medical history, specialized ocular surface condition, and tear samples for protein and PCR analysis from each pa
Patients with Pemphigus/Pemphigoid:Collect the complete medical history, s

Sponsors

The Second Xiangya Hospital of Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 80 Years

Inclusion criteria

Inclusion criteria: a) The age of the patients is between 16-80 years old; b) The gender is not limited; c) The survey is voluntary and there is no communication barrier.

Exclusion criteria

Exclusion criteria: Patients with other immune system diseases, cardiovascular diseases, malignant tumors in addition to the diseases studied.

Design outcomes

Primary

MeasureTime frame
Disease activity;Meibomian gland secretion score;

Secondary

MeasureTime frame
Tear film breakup time;

Countries

China

Contacts

Public ContactYan He

Beijing Tongren Hospital, Capital Medical University

yanza851130@163.com+86 135 4964 1130

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026